Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200049/S012

Amplatzer Amulet Left Atrial Appendage Occluder

ABBOTT MEDICAL · Decision date Sep 18, 2025

FDA DECISIONP200049/S012

What did the FDA approve?

FDA records P200049/S012 as a supplement to PMA P200049, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Sep 18, 2025.

FDA approval order statement

Approval for modifications to the Amplatzer Amulet Left Atrial Appendage Occluder Instructions for Use (IFU) and Patient Manual to remove a warning related to late pericardial effusions and to update your post implant medication regimen to include the use of oral anticoagulants.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Sep 18, 2025
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P200049/S012
Regulatory pathway
PMA supplement
Product code
NGV
Decision code
APPR
Decision date
Sep 18, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, appendage closure, left atrial.

Product code
NGV
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P200049/S012 received

    Application receipt date recorded by FDA.

  2. P200049/S012 · FDA decision

    Real-Time Process

  3. P200049/S013 · Related supplement

    Amplatzer Amulet Left Atrial Appendage Occluder

  4. P200049/S014 · Related supplement

    Amplatzer Amulet Left Atrial Appendage Occluder

  5. P200049/S015 · Related supplement

    Amplatzer Amulet Left Atrial Appendage Occluder

  6. P200049/S016 · Related supplement

    Amplatzer Amulet Left Atrial Appendage Occluder (Amulet)

  7. P200049/S017 · Related supplement

    Amplatzer Amulet Left Atrial Appendage Occluder

  8. P200049/S018 · Related supplement

    AmplatzerTM Amulet Left Atrial Appendage Occluder

  9. P200049/S021 · Related supplement

    Amplatzer Amulet Left Atrial Appendage Occluder

Timeline entries are records held by MedtechLedger for P200049. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200049

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementOct 23, 2025FDA
ABBOTT MEDICALPMA supplementDec 23, 2025FDA
ABBOTT MEDICALPMA supplementFeb 12, 2026FDA
ABBOTT MEDICALPMA supplementFeb 24, 2026FDA
ABBOTT MEDICALPMA supplementMar 19, 2026FDA
ABBOTT MEDICALPMA supplementMay 28, 2026FDA
ABBOTT MEDICALPMA supplementAug 28, 2026FDA

Explore the linked device profile

Other records with product code NGV

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
177 County Rd. B E., St. Paul, MN, 55117

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records